Matrine Targets BTF3 to Inhibit the Growth of Canine Mammary Tumor Cells
Open Access
- 30 December 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (1) , 540
Abstract
The canine mammary tumor model is more suitable for studying human breast cancer, and the safety concentrations of matrine and the biotin-labeled matrine probe were determined in canine primary mammary epithelial cells, and then selected canine mammary tumor cell lines CHMm and CHMp were incubated with matrine, and cell viability was detected by CCK-8. The biotin-labeled matrine probe was used to pull-down the targets of matrine in canine mammary tumor cells, and the targets were screened in combination with activity-based protein profiling (ABPP) and Genecards database, and verified by qPCR and western blot. The results showed that the maximum non-cytotoxic concentrations of matrine and biotin-labeled matrine probe in canine primary mammary epithelial cells were 250 μg/mL and 500 μg/mL, respectively. Matrine and biotin-labeled matrine probe had a proliferation inhibitory effect time-dependently on CHMm and CHMp cells within a safe concentration range, and induced autophagy in cells. Then BTF3 targets were obtained by applying ABPP and Genecards screening. Cellular thermal shift assay (CETSA) findings indicated that matrine could increase the heat stability of BTF3 protein. Pull-down employing biotin-labeled matrine probe with CHMm and CHMp cell lysates revealed that BTF3 protein was detected in the biotin-labeled matrine probe group and that BTF3 protein was significantly decreased by the addition of matrine. The qPCR and western blot findings of CHMm and CHMp cells treated with matrine revealed that matrine decreased the expression of the BTF3 gene and protein with the extension of the action time, and the impact was more substantial at the protein level, respectively.Keywords
Funding Information
- National Natural Science Foundation of China (32172938, 32172904, 202102140601019, 2022YFD1801101, 202204051001021, 20211331-16, 20211331-13)
- Shanxi Provincial Key Research and Development Project (32172938, 32172904, 202102140601019, 2022YFD1801101, 202204051001021, 20211331-16, 20211331-13)
- National Key Research and Development Program of China (32172938, 32172904, 202102140601019, 2022YFD1801101, 202204051001021, 20211331-16, 20211331-13)
- Special Fund for Science and Technology Innovation Teams of Shanxi Province (32172938, 32172904, 202102140601019, 2022YFD1801101, 202204051001021, 20211331-16, 20211331-13)
- Shanxi “1331 Project” (32172938, 32172904, 202102140601019, 2022YFD1801101, 202204051001021, 20211331-16, 20211331-13)
This publication has 48 references indexed in Scilit:
- Target Identification for Small Bioactive Molecules: Finding the Needle in the HaystackAngewandte Chemie International Edition, 2013
- Canine tumors: a spontaneous animal model of human carcinogenesisTranslational Research, 2012
- Dog models of naturally occurring cancerTrends in Molecular Medicine, 2011
- Crystal structures of NAC domains of human nascent polypeptide-associated complex (NAC) and its αNAC subunitProtein & Cell, 2010
- GIFtS: annotation landscape analysis with GeneCardsBMC Bioinformatics, 2009
- Breast Cancer Molecular Subtypes in Patients With Locally Advanced Disease: Impact on Prognosis, Patterns of Recurrence, and Response to TherapySeminars in Radiation Oncology, 2009
- The dog as a cancer modelNature Biotechnology, 2006
- Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-αJournal of Biological Chemistry, 2006
- The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisitedNature Reviews Cancer, 2003
- Sequencing and expression of complementary DNA for the general transcription factor BTF3Nature, 1990